Updates

Explore our latest insights, regulatory updates, and strategic reports for the life sciences sector.

Type (1)

Sectors (2)

Agriculture Biotech Chemicals Cosmetics Diagnostics Digital Health Food and Feed Healthcare Medical Devices Pharmaceuticals

Expertises

Advertising and Claims Commercial Contracts Corporate, Governance and Boardroom Counselling Data Protection, (Cyber)security and AI Due Diligence Environmental and Sustainability Financing and M&A Intellectual Property and Licensing Litigation Regulatory Compliance and Enforcement Spin-out and Starter Advisory Subsidies and Grants

Testimonial Chemicals Diagnostics Clear all

17 results

Newest first

Newest first Oldest first A–Z Z–A

Chemicals Regulatory Compliance and Enforcement Testimonial

Our team advised a client on the registration process under REACH.

Diagnostics Regulatory Compliance and Enforcement Testimonial

We have advised manufacturers, distributors and authorised representatives on all aspects of the IVDR, including assisting a diagnostics manufacturer with the classification and conformity assessment of its in vitro diagnostic medical devices under the new IVDR framework.

Chemicals Medical Devices Regulatory Compliance and Enforcement Testimonial

We have assisted a distributor of medical devices on questions pertaining to a cleaning solution regulated under the Biocidal Product Regulation.

Chemicals Medical Devices Environmental and Sustainability Regulatory Compliance and Enforcement Testimonial

We have advised a medical device manufacturer on the regulatory implications of the restriction on synthetic polymer microparticles for its products.

Chemicals Regulatory Compliance and Enforcement Spin-out and Starter Advisory Testimonial

We have advised a start-up on the legal limitations and requirements related to the transport of dangerous substances.

Biotech Diagnostics Corporate, Governance and Boardroom Counselling Due Diligence Financing and M&A Testimonial

Axon acted on behalf of an investor in connection with their investment in a clinical-stage biotech company developing first-in-class therapeutics and diagnostics for fibrosis. We conducted legal due diligence on the target company and reviewed the transaction documentation on behalf of the investors.

Diagnostics Healthcare Corporate, Governance and Boardroom Counselling Financing and M&A Testimonial

Axon assisted a Dutch IVD company in securing a EUR 24M equity financing round, advising on the transaction structure, investment documentation and related matters.